4.6 Review

INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology

期刊

GENES
卷 14, 期 10, 页码 -

出版社

MDPI
DOI: 10.3390/genes14101845

关键词

SHIP1; Alzheimer's disease risk gene; single-nucleotide polymorphism; microglia

向作者/读者索取更多资源

Alzheimer's disease is the most common form of dementia, with a high prevalence worldwide. Various risk factors, including gene variants, have been identified for this disease. Microglial cells play a critical role in brain protection and cellular homeostasis, and the SHIP1 protein has effects on their signaling pathways. Polymorphisms of the INPP5D gene are associated with an increased risk of Alzheimer's disease. However, there is limited knowledge about the regulation of INPP5D/SHIP1 expression and its influence on microglial signaling processes in relation to AD pathophysiology.
Alzheimer's disease (AD) is the most common form of dementia, accounting for approximately 38.5 million cases of all-cause dementia. Over 60% of these individuals live in low- and middle-income countries and are the worst affected, especially by its deleterious effects on the productivity of both patients and caregivers. Numerous risk factors for the disease have been identified and our understanding of gene-environment interactions have shed light on several gene variants that contribute to the most common, sporadic form of AD. Microglial cells, the innate immune cells of the central nervous system (CNS), have long been established as guardians of the brain by providing neuroprotection and maintaining cellular homeostasis. A protein with a myriad of effects on various important signaling pathways that is expressed in microglia is the Src Homology 2 (SH2) domain-containing Inositol 5 ' Phosphatase 1 (SHIP1) protein. Encoded by the INPP5D (Inositol Polyphosphate-5-Phosphatase D) gene, SHIP1 has diminutive effects on most microglia signaling processes. Polymorphisms of the INPP5D gene have been found to be associated with a significantly increased risk of AD. Several studies have elucidated mechanistic processes by which SHIP1 exerts its perturbations on signaling processes in peripheral immune cells. However, current knowledge of the controllers of INPP5D/SHIP1 expression and the idiosyncrasies of its influences on signaling processes in microglia and their relevance to AD pathophysiology is limited. In this review, we summarize these discoveries and discuss the potential of leveraging INPP5D/SHIP1 as a therapeutic target for Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据